Ceftaroline fosamil inj
Products billed under this code include Ceftaroline Fosamil, Teflaro.
Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Ceftaroline Fosamil, Teflaro.
Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Ceftaroline Fosamil | Apotex Corp. | 60505-6124-01 | 400 | $1,603.20 |
| Ceftaroline Fosamil | Apotex Corp. | 60505-6125-01 | 600 | $2,404.80 |
| Teflaro | Allergan, Inc. | 00456-0400-10 | 400 | $1,603.20 |
| Teflaro | Allergan, Inc. | 00456-0600-10 | 600 | $2,404.80 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $4.008 | −$0.382 | 10 MG | Ceftaroline fosamil inj | v1, posted September 17, 2026 |
| 3Q26 | $4.39 | +$0.136 | 10 MG | Ceftaroline fosamil inj | v1, posted September 15, 2026 |
| 2Q26 | $4.254 | +$0.015 | 10 MG | Ceftaroline fosamil inj | v1, posted September 15, 2026 |
| 1Q26 | $4.239 | +$0.011 | 10 MG | Ceftaroline fosamil inj | v1, posted September 15, 2026 |
| 4Q25 | $4.228 | −$0.016 | 10 MG | Ceftaroline fosamil inj | v1, posted September 8, 2026 |
| 3Q25 | $4.244 | +$0.253 | 10 MG | Ceftaroline fosamil inj | v1, posted March 10, 2026 |
| 2Q25 | $3.991 | +$0.045 | 10 MG | Ceftaroline fosamil inj | v1, posted March 10, 2026 |
| 1Q25 | $3.946 | +$0.011 | 10 MG | Ceftaroline fosamil inj | v1, posted December 19, 2025 |
| 4Q24 | $3.935 | −$0.091 | 10 MG | Ceftaroline fosamil inj | v1, posted June 11, 2025 |
| 3Q24 | $4.026 | +$0.167 | 10 MG | Ceftaroline fosamil inj | v1, posted June 11, 2025 |
| 2Q24 | $3.859 | +$0.024 | 10 MG | Ceftaroline fosamil inj | v1, posted March 11, 2025 |
| 1Q24 | $3.835 | −$0.021 | 10 MG | Ceftaroline fosamil inj | v1, posted December 19, 2024 |
| 4Q23 | $3.856 | −$0.031 | 10 MG | Ceftaroline fosamil inj | v1, posted October 10, 2024 |
| 3Q23 | $3.887 | +$0.122 | 10 MG | Ceftaroline fosamil inj | v1, posted June 5, 2024 |
| 2Q23 | $3.765 | −$0.015 | 10 MG | Ceftaroline fosamil inj | v1, posted February 23, 2024 |
| 1Q23 | $3.78 | +$0.038 | 10 MG | Ceftaroline fosamil inj | v1, posted December 6, 2023 |
| 4Q22 | $3.742 | +$0.017 | 10 MG | Ceftaroline fosamil inj | v1, posted June 22, 2023 |
| 3Q22 | $3.725 | +$0.16 | 10 MG | Ceftaroline fosamil inj | v1, posted June 9, 2023 |
| 2Q22 | $3.565 | −$0.001 | 10 MG | Ceftaroline fosamil inj | v1, posted December 14, 2022 |
| 1Q22 | $3.566 | +$0.057 | 10 MG | Ceftaroline fosamil inj | v1, posted June 8, 2022 |
| 4Q21 | $3.509 | −$0.03 | 10 MG | Ceftaroline fosamil inj | v1, posted June 2, 2022 |
| 3Q21 | $3.539 | +$0.183 | 10 MG | Ceftaroline fosamil inj | v1, posted June 2, 2022 |
| 2Q21 | $3.356 | +$0.009 | 10 MG | Ceftaroline fosamil inj | v1, posted March 1, 2022 |
| 1Q21 | $3.347 | – | 10 MG | Ceftaroline fosamil inj | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.